Article Information
History
- October 16, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Torben Redmer1,2,*,
- Elisa Schumann3,4,
- Kristin Peters5,
- Martin E. Weidemeier6,
- Stephan Nowak6,
- Henry W.S. Schroeder6,
- Anna Vidal1,
- Helena Radbruch3,
- Annika Lehmann7,
- Susanne Kreuzer-Redmer8,
- Karsten Jürchott9 and
- Josefine Radke5,*
- 1Institute for Medical Biochemistry, University of Veterinary Medicine Vienna, Vienna, Austria
- 2Institute of Pathology, Unit of Laboratory Animal Pathology, University of Veterinary Medicine Vienna, Veterinärplatz 1, Vienna, Austria
- 3Department of Neuropathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany
- 4German Cancer Consortium (DKTK), Partner Site Berlin, CCCC (Campus Mitte), Berlin, Germany
- 5Institute of Pathology, University Medicine Greifswald, Greifswald, Germany
- 6Department of Neurosurgery, University Medicine Greifswald, Greifswald, Germany
- 7Institute of Pathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany
- 8Nutrigenomics Unit, Institute of Animal Nutrition and Functional Plant Compounds, University of Veterinary Medicine Vienna, Vienna, Austria
- 9Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Center for Regenerative Therapies (BCRT), Berlin, Germany
- ↵*corresponding authors Torben Redmer, Email:
torben.redmer{at}vetmeduni.ac.at, Josefine Radke, Email:
josefine.radke{at}med.uni-greifswald.de
Posted October 16, 2023.
MET receptor activation by stromal cells serves as promising target in melanoma brain metastases
